IRVINE, Calif. (Aug. 21, 2025) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, proudly hosted its first-ever “Patient Day” event at its Advanced Patient Monitoring headquarters in Irvine, Calif. earlier this week, bringing together patients and BD associates in a powerful celebration of purpose, innovation and community.
“This event was a powerful reminder of why we come to work every day,” said Tim Patz, worldwide president of BD Advanced Patient Monitoring. “Seeing our associates connect directly with the patients they serve — and hearing how our technologies have changed their lives — was both humbling and energizing. It’s a testament to the heart and purpose that drives BD.”
Themed “Our Patients, Our Purpose,” the event offered a deeply moving experience for all attendees. Patients shared their personal stories in live panels, highlighting how BD’s technologies have impacted their lives.
One patient, Marisa Blake, shared: “ClearSight™ — a noninvasive hemodynamic monitoring system — gave my care team the insight they needed to act quickly. I was in the emergency department after a severe asthma attack, and the data showed I was hypotensive with dropping cardiac output. Once I received fluids, my recovery began — and I was able to go home the next day. Meeting the people who made that technology was incredibly emotional. When life is on the line, every second counts — and I’m so grateful to be one of the patients who benefited from their purpose-driven innovation. You make life matter.”
Associates from across BD APM participated in the day’s activities. In a particularly moving moment, team members from BD’s manufacturing sites joined the event in person, meeting face-to-face with patients whose lives were directly impacted by the products they helped create. This powerful exchange underscored the real-world significance of BD associates’ work and the deep connection between innovation and patient outcomes.
The day featured a giving-back initiative supporting Children’s Hospital of Orange County (CHOC). Over 100 care packages were assembled by associates at the Irvine campus, filled with items for pediatric patients. The activity reflected BD’s ongoing commitment to supporting local communities.
The idea of Patient Day was to bring BD’s purpose to life—placing patients at the heart of every conversation and every innovation. With participation from around 500 associates in Irvine, the event marked a meaningful milestone in BD APM’s journey to deepen its connection to those it serves.
This milestone event comes less than a year after BD acquired the Advanced Patient Monitoring business, formerly Critical Care, from Edwards Lifesciences in September 2024. Since then, the team has transitioned to its new headquarters at Spectrum Terrace in Irvine, which includes state-of-the-art R&D laboratories, designed to accelerate innovation and collaboration in support of BD’s mission to advancing the world of health™.
With the acquisition of Advanced Patient Monitoring, BD continues to be dedicated to partnering with clinicians to develop advanced patient monitoring solutions that help improve the quality of care for patients around the world. For more information visit BD's website.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X (formerly Twitter) @BDandCo or Instagram @becton_dickinson.
Contacts:
Media:
Fallon McLoughlin
BD Corporate Communications
619.614.6251
Fallon.McLoughlin@bd.com
Investors:
Adam Reiffe
BD Investor Relations
201.847.6927
adam.reiffe@bd.com